QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.129643v1 324/3/1227    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hamadmad, S. N. Articles by Hohl, R. J. PubMed PubMed Citation Articles by Hamadmad, S. N. Articles by Hohl, R. J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Cancer

CELLULAR AND MOLECULAR

Erythropoietin Stimulates Cancer Cell Migration and Activates RhoA Protein through a Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase-Dependent Mechanism

Departments of Pharmacology (S.N.H., R.J.H.) and Internal Medicine (R.J.H.), Carver College of Medicine, University of Iowa, Iowa City, Iowa

Erythropoietin (Epo) receptor (EpoR) is expressed in several cancer cell lines, and the functional consequence of this expression is under extensive study. In this study, we used a cervical cancer cell line in which EpoR was first found to be expressed and to correlate with the severity of the disease. We demonstrate that Epo is a chemoattractant for these cancer cells, enhancing their migration under serum-starved conditions. Using a Transwell migration system, we show that Epo enhances cancer cell migration in a dose- and time-dependent manner. The effect of Epo is dependent on the activity of two signaling pathways: the mitogen-activated protein kinase (MAPK) pathway and the RhoA GTPase pathway. We show that Epo activates both pathways in a Janus kinase-dependent manner and that this activation is required for Epo effects on cell migration. Furthermore, we use both pharmacological and genetic inhibitors to demonstrate that the activation of RhoA GTPase is dependent on the activity of the MAPK pathway, providing the first evidence for interaction between these two signaling cascades.

Address correspondence to: Dr. Raymond J. Hohl, Department of Internal Medicine, SE 313 GH, University of Iowa, Iowa City, IA 52242. E-mail: raymond-hohl{at}uiowa.edu